We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Telehealth Market Fuelled by Healthcare Demands

By HospiMedica International staff writers
Posted on 05 Feb 2010
As the more developed countries improve reimbursement and liability legislations, growth in the telehealth market is forecast to start picking up in response to the needs of an aging population. More...
These are the latest findings of InMedica (Wellingborough, United Kingdom), a point of care markets research company.

InMedica asserts that the initiatives taken by governments and private healthcare providers to increase reimbursements and reduce the legal and liability issues will help in the roll out of telehealth as a mainstream technology for remote disease and home-health monitoring. Consequently, InMedica predicts telehealth will start to be used by healthcare providers on a wider scale from the year 2012 onwards, and forecasts that the number of gateways used in telehealth applications will increase to over one million in 2014 and to around 3.6 million in 2018.

InMedica believes that in the short to medium term, health hubs--which currently constitute about 80% of the total gateways market--will remain the most practical solution for professional healthcare providers to supply to patients, as the infrastructure can then be standardized and simplified on a large scale. In addition, while the number of integrated cellular handsets used as telehealth gateways was estimated to be small in 2009, they are forecast to grow to over 350,000 in 2014.

"The use of mobile phones as telehealth gateways has had a surge of interest over the last couple of years; with patients and device companies recognizing the benefits of data transmission on the move,” said Neha Khandelwal, a market research analyst at InMedica. "We anticipate that cellular service providers will play an increasingly important role in the long-term future of the telehealth market.”

InMedica forecasts that health hubs will increasingly be used for managing disease conditions such as chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD). In chronic disease conditions such as diabetes, cellular handsets will also find an increasing acceptance. Diabetics are already used to regular self-monitoring with blood glucose meters, and a number of device companies have already launched diabetes management programs that use cellular handsets for transmitting blood-glucose readings to care professionals. For these patients, progressing to a telehealth service will not be a massive lifestyle change for them; moreover, receiving regular feedback on their condition would be a great benefit.

Related Links:

InMedica



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.